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Adipocytes hypertrophy is the main cause of obesity and its affliction such as type 2 diabetes (T2D). Since
superparamagnetic iron oxide nanoparticles (SPIONs) are used for a wide range of biomedical/medical
applications, we aimed to study the effect of SPIONs on 22 and 29 risk genes (Based on genewide association
studies) for obesity and T2D in human adipocytes. The mRNA expression of lipid and glucose metabolism
genes was changed upon the treatment of human primary adipocytes with SPIONs. mRNA of GULP1,
SLC30A8, NEGR1, SEC16B, MTCH2, MAF, MC4R, and TMEM195 were severely induced, whereas
INSIG2, NAMPT, MTMR9, PFKP, KCTD15, LPL and GNPDA2 were down-regulated upon SPIONs
stimulation. Since SEC16B gene assist the phagocytosis of apoptotic cells and this gene were highly
expressed upon SPIONs treatment in adipocytes, it is logic to assume that SPIONsmay play a crucial role in
this direction, which requires more consideration in the future.
A
dipocytes hypertrophy is the major cause of obesity, which promotes an inflammation state and this, in
turn, is implicated with pathophysiological metabolic disorders1,2 such as insulin resistance (IR), type 2
diabetes (T2D) and cardiovascular disease (CVD )3–6. While adipocytes play a central role in maintaining
lipid homeostasis and energy balance, recent studies suggest that adipose tissue (AT) is a key site for chronic
inflammation in obese human subjects and rodents7,8, and the macrophage content of AT in obese humans and
rodents increases dramatically. Meijer et al.2 has recently shown that adipocytes exhibit immune cell function and
are able to prime inflammation independent of macrophages. For example, hypertrophic adipocytes in obese
individuals alter the adipose tissue macrophages (ATMs) from resident to activated macrophages, secreting
secrete a range of cytokines and chemokines, which the latter recruit T cells towards AT. Since obesity and its
associated metabolic disorders are multifactorial disease and adipocytes hypertrophy is themain cause of obesity,
a comprehensive approach to identify biological and functional pathways of adipocytes-genes associated with the
diseases is necessary to clarify the molecular signatures of obesity and related diseases9–11. Based on epidemio-
logical and gene wide association studies (GWAS), one cluster of genes is considered as potential risk for obesity
and one gene cluster is potentially involved in the development of T2D12. In fact gene expression can be influenced
by many factors including organism’s internal signals as well as external environment factors13.
With the rapid advances of nanoscience and nanotechnology, our exposure to nanomaterials is significantly
increasing, however, the potential risks of these nanomaterials are largely unknown14,15. Because of their very
small size, nanoparticles (NPs) are capable of entering the human body by inhalation, ingestion, skin penetration
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andmacromolecules for long periods16,17. One particularly important
toxicological endpoint is genotoxicity, as large-scale gene expression
analysis provides a logical approach to study the detailed mechan-
isms of NPs toxicity. Recent studies have shown that NPs can
changes gene expression, thus, altering cellular functions or even
NPs could be the cause of toxicity18–20.
The aim of this study is to investigate whether superparamagnetic
iron oxide nanoparticles (SPIONs) affect down or up-regulation of
two cluster genes involved in the development of obesity and T2D in
human primary adipocytes. SPIONs are amongst the most used NPs
in medicine and they have been investigated for many applications,
including magnetic labeling21,22, cell isolation23, hyperthermia24, and
controlled drug release25. Due to their small size, these NPs can
produce excess reactive oxygen species (ROS) through their dissolu-
tion and formation of OOHN and OHN radicals from H2O2 via the
Fenton reaction26–28. Moreover, the obesity-induced oxidative stress
and localized inflammation in AT leads to important changes in
adipocyte gene expression with downstream effects on adipocyte
lipid metabolism and triglycerides as the stored energy in the lipid
droplets29,30. Since adipocytes hypertrophy is the main cause of obes-
ity and, in turn, T2D, we design this study to investigate the effect of
SPIONs on 22 and 29 risk genes associated with obesity and T2D in
human primary adipocytes.
Results
Synthesis and characterization of SPIONS. The Fourier transform
infrared spectroscopy (FTIR) generated spectra of bare SPIONs and
Carboxyethylsilanetriol (CES) grafted SPIONs are shown in Figure 1.
The broad band at 3400–3500 cm21 indicated the presence of surface
hydroxyl groups in bare SPIONs (Figure 1A). In the FTIR spectrum
of CES-grafted SPIONs (see Figure 1B), a strong peak at 1709 cm21 is
present due to acidic carbonyl (C5O) groups. Symmetric and asym-
metric stretching vibrations of methylene groups in CES showed
absorption bands at 2931 and 2867 cm21, respectively. Strong peak
at 1087 cm21 is due to C–O of CES group. The absorption band at
1460 cm21 is due to bending vibrations of CH2 groups of CES
groups.
TEM of the SPIONs is shown in Figure 2A and 2B confirming the
formation of SPIONs with a very narrow size distribution. More
quantitative analyses of particles were conducted using magnetome-
try and relaxometry. In Figure 2D and 2C, these corresponding
curves of the SPIONs are shown. A Langevin function was fitted to
the data, providing a particle radius R of 4.73 and saturation mag-
netization (Ms) of 56.48 A m2/kg for CES grafted SPIONs. Particle
radius and saturation magnetization (Ms) of bare SPIONs were
found to be 4.67 and 53.24 A m2/kg respectively. The Nuclear
Magnetic Relaxation Dispersion (NMRD)-profile of a SPIONs is
reported on Figure 2B. As it is clear from the picture, R1 values
increased after grafting with CSE. The curve represents a peak in
the high field (10–60 MHz), which is due is slow rotational correla-
tion time of self-agglomerates.
The effect of SPIONs on high risk genes associated with obesity
and type 2 diabetes in human primary adipocytes. The mRNA
analysis of high risk genes-associated with obesity and type 2
diabetes. The procedure for growth of human primary adipocytes
was already described2,7. To investigate whether SPIONs affect the
expression of high risk genes associated with obesity and T2D,
mRNA expression of 22 and 29 genes with high susceptibility to
obesity and T2D, respectively, were measured in human primary
adipocytes, which were already established as an energy metabo-
lism model. Upon SPIONs stimulation, most of these adipocyte-
associated high-risk genes for obesity were down-regulated and a
few up-regulated such as (e.g. INSIG2, NAMPT (also called
Visfatin, which is mainly present in adipocytes), MTMR9, PFKP,
KCTD15, LPL and GNPDA2 highly down-regulated) and (e.g.
NEGR1, SEC16B, MTCH2, MAF and MC4R highly up-regulated))
as depicted in Figure 3. However, three genes DGKG, NCR3 and
PTER were not detected in human primary adipocytes treated with
and without SPION.
ThemRNA expression of high-risk genes associated with T2Dwas
also measured in human primary adipocytes, upon SPIONs treat-
ment. As depicted in Figure 4, after stimulation of human primary
adipocytes with SPIONs, the majority of high risk genes linked with
T2D was highly down regulated such as PPAR-c, IGF2BP2, WFS1,
JAZF1, CAMK1D, PRC1, TCF7L2 and ZFAND6. The other genes
such as GULP1, SLC30A8, and TMEM195 were severely induced
upon SPIONs stimulation as compared to control. The mRNA of
the following genes KCNJ11, HHEX, and HNF1B were not detect-
able in either state.
Functional pathway and disorder analysis of obesity-associated
genes in human primary adipocytes upon SPION stimulation.
Figure 1 | Fourier Transform Infrared Spectroscopy (FTIR) of (A) bare and (B) CES-grafted SPIONs.
www.nature.com/scientificreports
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To gain more insight into the possible physiological functions of
obesity-associated genes, statistically enriched pathways and
diseases for the 22 genes involved in obesity were investigated
using KOBAS 2.0. KOBAS 2.0 was combined with hypergeometric
test and Benjamini-Hochberg FDR correction and considering all
human genes as background. This included Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathway, Pathway Interaction
Database (PID) curated, PID BioCarta, PID reactome, BioCyc,
Reactome and Protein Analysis Through Evolutionary Relation-
ships (PANTHER) pathway databases and KEGG disease, Genetic
Association Database (GAD), Functional disease ontology (FunDO),
Online Mendelian Inheritance in Man (OMIM) and National
Human Genome Research Institute (NHGRI) human disease
databases. Functional Pathways and disorders with a corrected p-
value , 0.05 were considered relevant and are shown in Figure 5
and 6 respectively. 4 functional pathways were found to be related to
Glycerolipid metabolism (KEGG), adipocytokine signaling pathway
(KEGG), N-acetylglucosamine metabolism (PANTHER) and 2-
arachidonoylglycerol biosynthesis (PANTHER). These data further
illustrated that lipids and glucose also have a key role in these
pathways. These four pathways were resulted from only 5/22
analyzed genes of which three genes were adipocytes differentiation
markers (e.g. ADIPOR1, ADIPOR2, and LPL) (Figure 5). Upon
SPION treatment, all genes found in this pathway were down-
regulated in adipocytes as compared to control adipocytes, except
DGKG, which was not detectable in either state.
Subsequently, we investigated whether obesity-associated genes
could have a role in human diseases. As displayed in Figure 6, 8
diseases were screened of which 5 appeared to be involved in lipid
metabolism and AT. Importantly, one disorder related to hyperin-
sulinism, whichmay be also caused by an increase of AT-mass. Based
on disorder enrichment analysis, obesity-associated genes involve in
the development of human polycystic ovary syndrome. The disorder
analysis also revealed that weight (i.e. 10 genes from 19 genes in this
pathway) and body mass index (BMI) (i.e. 10 from 23 genes in this
pathway) were considered as the most enriched disease processes,
which fits well with the known involvement of these two factors in
obesity disease, although it also suggests that the contribution of fat
mass increase to hyperinsulinism might be due to the expression of
insulin by AT and in particular adipocytes. It is noteworthy to men-
tion that weight is one of two factors in BMI equation and obesity can
be calculated by BMI. Importantly, disorder enrichment analysis
showed that metabolic disorders (i.e. 20 from 719 genes present in
this pathway) constituted approximately gene coverage of 3–4% as
identified by disorder enrichment analysis. As depicted in Figure 6,
the second hit of disorder analysis is BMI and covered by 10 genes of
Figure 2 | Magnetization curves, NMRDprofiles, andTransmission ElectronMicrographs of bare andCES-grafted SPIONS. (A)Magnetization curves
for bare and CES-grafted SPIONs, (B) NMRD profiles of bare and CES-grafted SPIONs, and Transmission Electron Micrographs of (C) bare and (D)
CES-grafted SPIONs.
www.nature.com/scientificreports
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which 5 genes (i.e.MCR4, TMEM18,MTCH2, NEGR1 and SEC16B)
show a higher mRNA expression in SPION adipocytes than control
adipocytes and 4 genes display an opposite version. DGKG was not
detected in both states. Moreover, the sixth hit of disorder analysis is
obesity with 5 genes of which after SPIONs treatment the expression
of two genes (i.e.MAF andMC4R) go up and two genes (i.e.NAMPT
and INSIG2B) goes down and one gene (i.e. PTER) not detected in
both states.
Functional pathway and disorder analysis ofT2D-associated genes
in human primary adipocytes upon SPIONs stimulation. To shed
more light into the possible physiological functions of T2D-
associated genes, statistically enriched pathways and diseases for
the 29 genes involved in T2D were detected using the same proce-
dure and databases as we applied for obesity-associated genes.
Functional Pathways and disorders with a corrected p-value ,
0.05 were considered relevant and are shown in Figure 7 and 8
Figure 3 | mRNA expression of 22 genes associated with obesity as found by GWAS was analyzed in adipocytes after treatment with and without
SPIONs. mRNA expression of 22 genes was expressed as 2log values on the y-axis. Relative mRNA intensity was obtained from two measurements.
Figure 4 | mRNA expression of 29 genes associated with type 2 diabetes (T2D) as found by GWASwas analyzed in adipocytes after treatment with and
without SPIONs. mRNA expression of 29 genes was expressed as 2log values on the y-axis. Relative mRNA intensity was obtained from two
measurements.
www.nature.com/scientificreports
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Figure 5 | Enriched pathways related to the 22 genes found by Gene Wide Association Study (GWAS) as risk genes for obesity. The abbreviations or
description is: Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Analysis Through Evolutionary Relationships (PANTHER). Only
pathways with corrected p-values , 0.05 are presented. Abbreviations in Figure are: ADIPOR1 and 2 (Adiponectin receptor gene 1 and 2), LPL
(lipoprotein lipase), DGKG (Diacylglycerol kinase gamma), and Glucosamine-6-phosphate isomerase 2. The complete list of abbreviations was shown in
table 1.
Figure 6 | Enriched disorder pathways related to the 22 genes found by GWAS as risk genes for obesity. The abbreviations or description is: Genetic
Association Database (GAD), and Functional disease ontology (FunDO). Only disorders with corrected p-values , 0.05 were included in the analysis.
The complete list of abbreviations was shown in table 1.
www.nature.com/scientificreports
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respectively. 4 functional pathways were found of which 2 played
a role in the cell cycle and cell check point (i.e. PID BioCarta)
as depicted in Figure 7. However, only one pathway was found to
be directly related to diabetes (i.e. KEGG). The last detected
functional pathway was Thyroid cancer (i.e. KEGG). These 4
functional pathways were found by PID BioCarta and KEGG
databases and include 6/29 genes of which mRNA expression of 4
genes (i.e. PPARc, TCF7L2, CDKN2A and CDKN2B) were down-
regulated or not detected upon treatment of adipocytes with SPION
and two genes (i.e. HHEX and HINF1B) were not detected in either
state.
T2D-associated genes were also examined whether they could
have a role for human diseases. As depicted in Figure 8, the majority
of found disorders are T2D as expected. Also 4 disorders were iden-
tified of which two diseases related to the metabolism and two assoc-
iated with glucose metabolism. These two disorders also considered
to be truly involved in T2D. Another disorder was matched to the
intracranial aneurysm, which may be due to T2D as cause of this
disease. Disorder enrichment analysis logically revealed that (i.e. 15–
24/29 genes) T2D, glucose metabolism in general were considered as
the most enriched disease processes identified by disorder enrich-
ment analysis, which matches well with the known role of these
factors in T2D disease. Since all disorders ended to T2D, we have
chosen to dissection the hit number 1 (Figure 8), which pointed
to T2D includes 18 genes of 25 genes found in this pathway (i.e.
GAD database; hit 1); a coverage of 70% (18525 genes). Upon
SPIONs treatment, importantly, mRNA expression of 11 genes (i.e.
CDC123, CAMK1D, IGF2BP2, CDKN2A, JAZF1, FTO, LGR5,
TCSF7-L2, PPARc, CDKN2B, and THADA) was down-regulated
as compared to control adipocytes. Two genes (i.e. KCNJ11 and
HHEX) were neither detected in SPIONs adipocytes nor control.
However, mRNA expression of four genes (i.e. ADAMTS9,
CDKAL1, NOTCH2 and TSPAN8) was equal for both states and
one gene (i.e. SLC30A8) up-regulated in SPION adipocytes.
Functional pathway and disorder analysis of combined set genes
associated with obesity and T2D in human primary adipocytes
upon SPION stimulation. To obtain further insight into the
specific roles that obesity- and T2D-associated genes might have in
pathophysiology, we also analyzed the combined set of genes linked
with these two disorders (see Table 1, Figure 9 and Figure 10).
KOBAS version 2.0 was also applied to detect the functional and
disorder pathways in this combined set of genes. As exhibited in
Figure 9, unexpectedly, we found only three pathways of which
two pathways appeared to have a role in lipid metabolism and one
pathway in cell cycle. PPARc and LPL genes were accounted for lipid
metabolism, and CDKN2A and CDKN2B are responsible for cell
cycle31–33. Upon SPIONs treatment, mRNA expression of LPL and
PPARc severely down-regulated in adipocytes as compared to con-
trol adipocytes. Regarding CDKN2A and CDKN2B, as depicted in
Figure 3 and 4 they are slightly down-regulated after treatment of
adipocytes with SPIONs.
Based on disorder enrichment analysis, we detected 19 hits of
which weight, BMI and T2D were considered as the most enriched
disease process identified by disorder enrichment analysis, which fits
well with the known involvement of these genes in the development
of these two diseases as noted by Gene Wide Association study (i.e.
GWAS). As depicted in Figure 10, The GAD and KEGG databases
analysis (i.e. hit number 1 and 2 respectively) revealed that diabetes
(i.e. 18 from 25 genes found in hit 1, and 16 from 19 genes detected in
hit 2) and weight (i.e. 11 from 19 genes identified by GAD database
analysis; hit number 4) as well as BMI (i.e. 11 from 23 genes screened
in this database; hit number 5) are the most enriched disease
pathways. T2D covered approximately 75–80% of this disease
Figure 7 | Enriched pathways related to the 29genes found byGWAS as risk genes for type 2 diabetes (T2D). The abbreviations or description is: Kyoto
Encyclopedia of Genes and Genomes (KEGG), and gene Analysis through Evolutionary Relationships (PANTHER). Only pathways with corrected
p-values , 0.05 are presented. Abbreviations are: CDKN2A and B (Cyclin-dependent kinase inhibitor 2A and B, isoform 4), PPARc (Peroxisome
proliferator-activated receptor gamma), HHEX (Hematopoietically expressed homeobox protein HHEX), TCF7L2 (Transcription factor 7-like 2)
HNF1B (Hepatocyte nuclear factor 1). The complete list of abbreviations was shown in table 1.
www.nature.com/scientificreports
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pathway and weight/BMI showed pathway coverage of about 50%.
The disorder analysis obesity-associated genes are also involved in
the human polycystic ovary syndrome. Disorder T2D was identified
by GAD database (i.e. hit number 1) includes 18 genes of which,
upon SPIONs treatment, 7 genes like CDKAL1were severely, 4 genes
slightly such as CDKN2B down-regulated. However, the expression
of 4 genes was remained unchanged like ADAMTS9 and two genes
(i.e.HHEX and KCNJ11) were not detected, when we compare con-
trol adipocytes with SPION adipocytes. Notably, only 1 gene (i.e.
SLC30A8)was highly expressed upon SPION treatment as compared
to control (Figure 3 and Figure 10). Surprisingly, based on GAD
database (hit 5) BMI disorder is the most prominent disease. In this
regard, the mRNA expression of 5 genes (MC4R, TMEM18,
MTCH2, SEC16B, and NEGR1) was highly up-regulated in
SPIONs adipocytes comparing with control adipocytes. DGKG gene
was not detected in either state. The rest of genes like FTO were
expressed higher in control adipocytes than SPIONs adipocytes
(see Table 1 and Figure 10, hit 5).
Differences and similarities between before and after treatment of
human adipocytes with SPIONs with respect to mRNA expres-
sion.We found the expression of 6 genes from 22 genes-linked with
obesity up-regulated after treatment with SPION as compared to
control adipocytes. Notably, the mRNA expression of NEGR1,
SEC16B and MAF was not detectable and MCR4 was just detected
as traces (Figure 3 and table 1), indicating that 30% of the obesity
genes were up-regulated after treatment of the cells with SPIONs.
Whereas, the mRNA of INSIG2, NAMPT, and MTMR9 were not
detectable upon treatment of adipocytes with SPIONs as compared
to control cells. In addition, three genes (i.e. DGKG, NCR3, and
PTER) were not expressed in both states; upon SPION treatment
and control. Finally, the rest of obesity-associated genes were
shown to have a higher mRNA expression in control adipocytes
than adipocytes after SPIONs treatment.
We observed an equal mRNA expression of NOTCH2,
ADAMTS9, CDKAL1, TSPAN8 and PRDM6 (as a part of T2D-
associated genes) for both control and SPION adipocytes. There
was no mRNA expression observed for HHEX, HNF1B and
KCNJ11 for either state. As depicted in Table 1 and Figure 4,
mRNA expression of the following genes MTNR1B, GULP1,
KCNJ6, CDKN2B, andTMEM195were found to be higher in human
adipocytes upon SPIONs treatment than control adipocytes. The
remaining genes from T2D cluster genes showed a higher mRNA
expression in control adipocytes than SPION adipocytes.
Discussion
An imbalance or dysfunction of adipocytes leads to obesity. Obesity is
linked with metabolic disorders and in particular insulin resistance,
Figure 8 | Enriched disorder pathways linked to the 29 genes found by GWAS as risk genes for type 2 diabetes (T2D). The abbreviations are: Kyoto
Encyclopedia of Genes and Genomes (KEGG), Genetic Association Database (GAD), and Functional disease ontology (FunDO). Only disorders with
corrected p-values , 0.05 were included in the analysis. The complete list of gene abbreviations was shown in table 1.
www.nature.com/scientificreports
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T2D, and the prevalence of these diseases are increasing worldwide2.
As SPIONs have several unique properties that maintain various
medical applications such as drug delivery, transfection, and
imaging34, we studied the effect of SPIONs on the expression of the
22 and 29 genes-associated with obesity and T2D in human adipo-
cytes respectively.
In order to mitigate any agglomeration of SPIONs and avoid pos-
sible shape related interference with our design15, we used CES grafted
SPIONs to stabilize particles and avoid agglomeration. The results of
VSM and relaxometry analysis confirmed the superparamagnetic
behavior along with success of coating. In fact, slight increase in
magnetic saturation and relaxivity can be attributed to the increase
of the weight and volume of magnetite nanoparticles after grafting
with CES35,36.
The reason why we have chosen these specific genes to study the
effect of SPIONs is that these genes were found to be associated with
Table 1 | The analysis of Risk genes associated with obesity and type 2 diabetes in adipocytes after treatment with and without SPIONs
Gene Name Gene Description Disease (GWAS) MW (kDa) pI AD Exp Adipocytes 1 SPION
NEGR1 Neuronal growth regulator 1 OBESITY 24.7 6.29 ND UP
SEC16B Protein transport protein Sec16B OBESITY 116.0 5.71 ND UP
ADIPOR1 Adiponectin receptor protein 1 OBESITY 42.6 6.53 Yes Down
ADIPOR2 Adiponectin receptor protein 2 OBESITY 43.8 6.11 Yes Down
TMEM18 Transmembrane protein 18 OBESITY 16.2 9.35 Yes UP
INSIG2 Insulin-induced gene 2 protein OBESITY 24.7 8.16 Yes Down(ND)
ETV5 ETS translocation variant 5 OBESITY 57.8 5.43 Yes Down
DGKG Diacylglycerol kinase gamma OBESITY 89.1 6.36 ND ND
GNPDA2 Glucosamine-6-phosphate isomerase 2 OBESITY 31.0 6.45 Yes Down
NCR3 Natural cytotoxicity triggering receptor 3 OBESITY 19.2 8.91 ND ND
AIF1 Allograft inflammatory factor 1 OBESITY 16.7 5.97 Yes Down
NAMPT Nicotinamide phosphoribosyltransferase OBESITY 55.5 6.69 Yes Down(ND)
MTMR9 Myotubularin-related protein 9 OBESITY 63.4 5.98 Yes Down(ND)
LPL Lipoprotein lipase OBESITY 53.1 8.37 Yes Down
PTER Phosphotriesterase-related protein OBESITY 39.0 6.07 ND ND
PFKP 6-phosphofructokinase OBESITY 22.8 8.87 Yes Down
MTCH2 Mitochondrial carrier homolog 2 OBESITY 33.3 8.25 Yes UP
MAF Transcription factor Maf OBESITY 38.4 6.44 ND UP
SH2B1 SH2B adapter protein 1 OBESITY 79.3 5.26 Yes Down
MC4R Melanocortin receptor 4 OBESITY 36.9 7.88 Yes UP
KCTD15 BTB/POZ domain-containing protein KCTD15 OBESITY 31.9 7.05 Yes Down
CTNNBL1 Beta-catenin-like protein 1 OBESITY 85.4 5.53 Yes Down
NOTCH2 Neurogenic locus notch homolog protein 2 T2DM 132.1 4.65 Yes 5
THADA Thyroid adenoma-associated protein T2DM 219.6 5.71 Yes Down
PPARG Peroxisome proliferator-activated receptor gamma T2DM 57.6 5.61 Yes Down
ADAMTS9 A disintegrin & metalloproteinase with
thrombospondin motifs 9
T2DM 216.4 8.13 Yes 5
IGF2BP2 Insulin-like growth factor 2 mRNA-binding protein 2 T2DM 66.1 8.48 Yes Down
WFS1 Wolframin T2DM 100.2 8.34 Yes Down
CDKAL1 Threonylcarbamoyladenosine tRNA methylthiotransferase T2DM 65.1 7.2 Yes 5
JAZF1 Juxtaposed with another zinc finger protein 1 T2DM 27.0 8.63 Yes Down(ND)
SLC30A8 Zinc transporter 8 T2DM 40.7 6.11 ND UP
CDKN2A Cyclin-dependent kinase inhibitor 2A, isoform 4 T2DM 61.1 9.13 Yes Down
CDKN2B Cyclin-dependent kinase inhibitor 2B, isoform 4 T2DM 14.7 6.08 Yes Down
CDC123 Cell division cycle protein 123 homolog T2DM 32.1 4.63 Yes Down
CAMK1D Calcium/calmodulin-dependent protein kinase type 1D T2DM 42.9 6.77 Yes Down
HHEX Hematopoietically-expressed homeobox protein HHEX T2DM 23.9 7.10 ND ND
TCF7L2 Transcription factor 7-like 2 T2DM 63.4 9.03 Yes Down(ND)
KCNJ11 ATP-sensitive inward rectifier potassium channel 11 T2DM 43.5 8.15 ND ND
TSPAN8 Tetraspanin-8 T2DM 26.4 5.48 Yes 5
LGR5 Leucine-rich repeat-containing G-protein coupled
receptor 5
T2DM 99.9 6.12 Yes Down(ND)
FTO Alpha-ketoglutarate-dependent dioxygenase FTO T2DM 58.2 5.10 Yes Down
HNF1B Protein regulator of cytokinesis 1 T2DM 61.3 7.39 ND ND
PRC1 Glucokinase regulatory protein T2DM 71.6 6.29 Yes Down
GCKR Transmembrane protein 195 T2DM 68.6 6.24 Yes Down(ND)
TMEM195 Alkylglycerol monooxygenase T2DM 51.5 7.75 Yes UP
ZFAND6 AN1-type zinc finger protein 6 T2DM 22.5 6.87 Yes Down(ND)
KCNJ6 G protein-activated inward rectifier potassium
channel 2
T2DM 48.4 5.24 Yes UP
CREB5 Cyclic AMP-responsive element-binding protein 5 T2DM 56.9 8.76 Yes Down
PRDM6 Putative histone-lysine N-methyltransferase PRDM6 T2DM 64.4 7.93 Yes 5
GULP1 PTB domain-containing engulfment adapter protein 1 T2DM 34.4 8.04 Yes UP
MTNR1B Melatonin receptor type 1B T2DM 40.1 9.12 ND UP
Gene name, gene description, pI (isoelectric focusing point), the Molecular weight (Mw) and the mRNA expression of each studied gene were shown in this table. Other abbreviations and symbols are: ND
(not detectable), Down (down-regulation), UP (Up-regulation) and5 (equal mRNA expression of that gene was observed for adipocytes (control) and upon SPIONs treatment. The Mw was expressed in kDa.
pI was resulted from whole amino acid sequence of each protein and derived from www.expasy.org.
www.nature.com/scientificreports
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Figure 9 | Enriched functional pathways related to a combined set of the 22 and 29 genes found by GWAS as risk genes for obesity and type 2
diabetes (T2D) respectively. Only pathways with corrected p-values , 0.05 are presented. Pathway Interaction Database (PID) BioCarta was found
significant. All three pathways were found by PID BioCarta database. The identified genes responsible for these three pathways are CDKN2A, CDKN2B,
PPARc and LPL (see also table 1).
Figure 10 | Enriched disorder pathways related to a combined set of the 22 and 29 genes found by GWAS as risk genes for obesity and type 2 diabetes
(T2D) respectively. Only disorders with corrected p-values, 0.05 were included in the analysis. The complete list of gene abbreviations was shown in
table 1. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway Genetic Association Database (GAD), and Functional disease ontology (FunDO)
were found significant. The databases used in this combined set was, PIDcurated PID reactome, BioCyc, Reactome and Protein Analysis through
Evolutionary Relationships (Panther) pathway databases and KEGG.
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obesity and T2D in several and large genome-wide association stud-
ies (GWAS). Moreover, all these genes were also validated by single
nucleotide polymorphisms (SNPs)37.
For the functional pathway and disorder analysis in the current
study, we include many databases. The increase of number of data-
bases ensures the reduction of the chance for missing pathway(s).
That was the reason why we applied multiple databases to detect the
potential functional and disorder pathways link to the genes assoc-
iated with obesity and T2D.
The pathway analysis ended to four functional pathways with
ADIPOR1 and R2 as well as LPL as major genes in these pathways.
These three genes play an important role in lipid metabolism and all
function as anti T2D31,38–41 and a reduction of these three genes con-
tributes to the metabolic dysfunction and its associated disorders as
consequences. However, all these three genes were down-regulated
upon SPION treatment. This may mean that SPIONs has a dis-
advantage in this context. Interestingly, mRNA expression of 5 genes
was found to be highly up-regulated upon SPIONs treatment of
adipocytes, and the concrete function of some of them still under
investigation. However, MTCH2 is involved in the depolarization of
mitochondria42. Two scenarios is possible 1- upon SPIONs treat-
ment, MTCH2 gene expresses very high, which in turn lead to the
depolarization of mitochondria and as consequence the leaking of
mitochondriamembrane, and 2- if the first option is true; that means
that SPIONs may enter the cell and may subsequently enter to the
mitochondria.
The functions of GULP1 are to assist the phagocytosis of the
apoptotic cells and also modulate the cholesterol transport43.
Intriguingly, mRNA of GULP1 was highly expressed in SPIONs
adipocytes as compared to control. In obese adipocytes, the efficiency
of mitochondria function is reduced, long chain fatty acids will be
accumulated within adipocytes. ATMs are meant to phagocyte the
not functional components of the cells. It is already present reports
that SPIONs produce ROS44. Thus, it may then logic to assume that
SPIONs produce ROS, which, in turn, affect themRNA expression of
GULP1 that possibly contributes to the function of macrophages in
the phagocytosis of apoptotic cells43. Thus, we are allowed to assume
that this effect of SPIONs is a positive effect.
T2D-associated genes showed four functional pathways, which
pointed to the cell cycle with the involvement of the following
PPARc, TCF7L2, CDKN2A, and CDKN2B genes. Notably, all these
four genes from slightly to severely down-regulated in SPIONs adi-
pocytes, indicating that cell cycle damage may contribute to the
development of T2D and the use of SPIONs in biological application
may affect the regulation of cell cycle31. Interestingly, we found that
the most of genes associated with the risk for T2D were down-
regulated after treatment of adipocytes with SPIONs and only one
gene (i.e. SLC30A8) was up-regulated, which ensure the transport of
accumulated Zinc to the intracellular vesicles45. Thus, SPIONs
appeared to affect the expression of this gene. It must be noted that
the function of some of these genes remained to be completed or to be
under the investigations.
Surprisingly, after the combination of two clusters of genes, we
observed only three pathways pointed to AT and cell cycle. This
indicates that not only the role of adipocytes cannot be ignored in
the development of obesity but also cell cycle may be a target of
intervention for the therapy of these metabolic disorders. As it is
already established, PPARc and LPL are considered as anti-aging-
related diseases such as T2D and atherosclerosis32,46–48. Based on this
finding, we may cautiously assume that SPIONs may behave as pro-
aging-linked disorders rather than anti-aging-related diseases.
Based on this study, we found that SPIONs play clearly a crucial
role in the expression of the selected genes based on GWAS. The
expression of some genes increases, while the expression of other
genes decreased when we treated the adipocytes with SPIONs.
Moreover, SPIONs may play dual roles (i.e. positive and negative).
Also, the application of SPIONs in human primary adipocytes as an
established model for the study of energy metabolism provides us
more knowledge about these types of NPs. We may cautiously
conclude that SPIONs influence the gene expression of lipid and
glucose metabolism. Thus, the effect of SPIONs must be extended
to other cells in vitro and in particular in vivo. Also the interaction
between SPIONs and adipocytes-secreted proteins must be investi-
gated in future to gain more knowledge about the protein content of
Corona (surface of SPIONs coated with proteins), which helps us to
understand better the role of SPIONs in Nano- Biological applica-
tion. We also find that the link between SPIONs, mitochondria, and
adipocytes must not be ignored.
Methods
FeCl2.4H2O, FeCl3.6H2O, diethylene glycol, o-(2-aminoethyl)-o’-methylpolyethy-
lene glycol (PEG-NH2, MW 5 750), and N,N-dimethylformamide (DMF) were
purchased from Sigma-Aldrich, Germany. Carboxyethylsilanetriol (CES) was
granted by Wacker-Chemie GmbH, Burghausen, Germany. Preadipocytes were
purchased from LONZA (Belgium). All media and supplements for differentiation of
the preadipocytes were provided by LONZA and PromoCell (Germany).
Synthesis of SPIONs. In order to obtain nanoparticles with a narrow size
distribution, the polyol-method was employed49. Briefly, 5 mL of an aqueous solution
of FeCl2.4H2O (0.045 M) and FeCl3.6H2O (0.0375 M) were added to 250 mL of
diethyleneglycol. The mixture was heated to 170uC and maintained at this
temperature for 15 min before addition of the base (i.e. solid NaOH (0.375 M).
Subsequently, temperature wasmaintained at 170uC for a period of 1 h before cooling
to 60uC. The synthesized SPIONs were collected with a neodymium magnet and
washed with 100 mL of a HNO3 (1 M) solution.
Grafting of SPIONs with Carboxyethylsilanetriol (CES). CES was grafted on the
surfaces of SPIONs, as described elsewhere49. Briefly, 100 ml of nanoparticle solution
(0.3 M iron) was added to 100 ml DMF and 45 ml of 0.15 M CES was slowly added
before adding 25 ml water followed by 15 ml of NaOH solution (1 M) at room
temperature and under homogenization (about 8000–24,000 rpm). The solution was
heated to 100uC for 24 h under continuous stirring. The SPIONs were precipitated by
addition of acetone/ether (50/50) mixture and collected with neodymium magnet.
The precipitate was washed with acetone several times and finally dispersed in water.
Excess of silane derivative and other chemicals were removed by dialysis using a
dialysis bag (Spectrum Laboratories, Inc; MWCO 5 10000) for 48 h in water.
Characterizations of SPIONs. Fourier transform infrared (FTIR) spectra were
collected using a PerkinElmer Spectrum 100 spectrometer in the range of 4000–
650 cm21, and each spectrum was obtained by averaging 32 interfere grams with a
resolution of 4 cm21. Samples for FTIR analysis were prepared by lyophilizing SPION
suspensions in water and a thin film of lyophilized SPIONs was placed on the
attenuated total reflectance crystal for spectral recording.
The magnetization of the SPIONS in a variable magnetic field was measured using
a vibrating-sample magnetometer (VSM) with a sensitivity of 1023 emu and a
maximum magnetic field of 10 kOe. The magnetic field was changed uniformly at a
rate of 66 Oe/s.
The morphology and size of the particles was investigated using transmission
electron microscopy (TEM),( ZEISS, EM-10C, Germany) operating at 100 kV. For
sample preparation, a drop of the SPOIN suspension was placed on a copper grid and
was dried under vacuum. Phase characterization was accomplished using the XRD
(X-ray powder diffraction, Siemens, D5000, Germany) technique with Cu KR radi-
ation, and the Scherrer method was used for particle size determination.
All these relexometric measurements were performed at room temperature. In the
plot shown in this work, themagnetic field is expressed in terms of the proton Larmor
frequency. The results are represented in terms of longitudinal relaxivities.
Cell culture. Human primary preadipocytes (Lonza) were culture to confluence in
growth media provided by PromoCell in 5% CO2 at 37uC. When the cells reached
confluence, the growth media were removed and replaced with preadipocyte
differentiation FCS free media supplemented with (provided by promoCell) of
0.5 mM 3-isobutyl-1-methyxanthine, 400 ng/ml dexamethasone, 0.5 ug/ml bovine
insulin, L-thyroxin 9 ng/ml, ciglitazone 3 ug/ml and d-biotin 8 ug/ml for 72 hours.
After Three days, the differentiation media were removed and replaced with adipocyte
nutrition medium containing 3% FCS, d-biotin 8 ug/ml, 0.5 ug/ml bovine insulin,
and 400 ng/ml dexamethasone for a period of 16 days (terminal phase of
differentiation). After maturation of adipocytes, the nutrition media were and the cells
were washed 5 times with the differentiation FCS free media. After wash steps, the
cells were incubated with the differentiation media with and without SPION for 30 h.
Then the cells were washed with PBS for 5 times. Then the cells were lyzed and total
RNA were extracted. The characterization of the cells was already established2,50–52.
mRNA expression array. Total RNA was extracted from human primary adipocytes
cultured in 6 wells (9 cm2). The quality and concentration of the RNA were
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determined by Bioanalyser using the Agilent RNA 6000 Nano kit (Agilent, The
Netherlands).
Total Prep RNA Amplification Kit was used to amplify and label the RNA.
(Applied Biosystems, The Netherlands). Total RNA was used to make cDNA and the
concentrations were determined in nanodrop. cRNAwas used to Biotinylate applying
RNA Amplification Kit (Ambion, Inc., Austin, TX) according to the manufacturer’s
instructions starting with 200 ng total RNA. Samples were purified using the RNeasy
kit (Qiagen, Valencia, CA). Hybridization to the Sentrix HumanRef-12 Expression
BeadChip array (Illumina, San Diego, CA, USA), washing, and scanning were per-
formed according to the Illumina BeadStation 500 manual (revision C). One
BeadChip with twelve arrays were used. Slide was scanned immediately.
After the scanning, the following steps were performed: 1- quality check, 2-
background correction, and utile normalization of the data using Beadstudio
Expression module v 3.2.7. and 3- Statistics and the generation of gene lists using
Genespring GX 7.3.1 (Agilent). P-values were corrected for multiple testing using
Benjamini and Hochberg False Discovery Rates.
Functional and disorder pathway analysis. KOBAS version 2.0 combined with
hypergeometric test and Benjamini-Hochberg FDR correction were performed to
screen the enriched pathways and disorders, which obesity- and T2D-associated
genes may have a role53.
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